Economy

Pfizer to seek vaccine approval in November

Pfizer to seek vaccine approval in November”

The firm is conducting final phase-three trials of a vaccine it is co-developing with German partner BioNTech.

The website said on Monday that 481,613 people had taken the vaccine while an additional 93,653 had applied to be inoculated, according to the report. Trials for a vaccine produced by AstraZeneca remain frozen by the Food and Drug Administration after a neurological issue was discovered in a trial participant in the UK.

Without further data on how effective the vaccine is and how long immunity from it may last, it's also hard to know what impact any of the shots now in phase III trials will have on controlling the pandemic. There are now no COVID-19 vaccines approved by USA regulators, although a handful are in late-stage trials to prove they are safe and effective.

Bourla noted, "The timelines above reflect our best estimates of when these important milestones could be achieved". The subject expert committee said the sample size of Phase II study was too small for granting market authorisation and asked the company to submit a protocol for Phase III trials. "It has said that it may have interim data on its 30,000 person trial as soon as November", as reported by Reuters.

More news: Japan to release Fukushima's contaminated water into sea

Golikova told Putin that post-registration trials of EpiVacCorona will involve 40,000 volunteers across Russian Federation. Hundreds of thousands of people have been given experimental vaccines in late-stage trials as part of an emergency inoculation programme launched in July. Even if that were so, a pre-election vaccine would mean the Food and Drug Administration would have to give an nearly immediate thumbs-up.

The coronavirus vaccine will be free for all Americans, but initially the COVID-19 vaccine will likely be available to higher-risk groups, such as health care workers, essential workers, the elderly, and those with health conditions that make them more vulnerable to COVID-19.

As per RDIF, it will supply 100 million doses of its potential COVID-19 vaccine to India drug company Dr Reddy's Lab.

The letter was welcomed by Eric Topol, a physician-scientist at Scripps Research Translational Institute who joined other experts in sending a letter to Bourla in late September, asking the company not to seek authorization for a vaccine before late November.



Like this

loading...
loading...

Latest


17 October 2020
How major USA stock indexes fared Friday
Declining issues outnumbered advancing ones on the NYSE by a 1.51-to-1 ratio; on Nasdaq, a 1.95-to-1 ratio favored decliners. The S&P index recorded 49 new 52-week highs and no new low, while the Nasdaq recorded 80 new highs and 12 new lows.

17 October 2020
US Jobless Claims Hit Highest Since August in Unexpected Jump
While the economy did see more jobs created over the summer, this hiring is slowing and stalling as winter approaches. Nationwide, on average, unemployment benefits replace about 33% of what recipients earned at their previous job.

17 October 2020
Outdoor trick-or-treating can be safe with precautions: Dr. Tam
Garcetti said Los Angeles is following the county's COVID-19 health directives, which have not banned trick-or-treating. Activity hours are now expected to remain in place from 6-8 p.m. on Saturday, Oct. 31, Halloween night.

17 October 2020
Brexit: Angela Merkel urges both sides to keep negotiating
German Chancellor Angela Merkel, Europe's most powerful leader, said after the summit that compromise would be needed for a deal. EU chief Ursula von der Leyen said on Friday European negotiators will be in London next week to pursue post-Brexit talks.

17 October 2020
Ontario reports 712 new COVID-19 cases as hospitalizations continue slow climb
The new restrictions were implemented in less than 24 hours in Toronto, Peel Region and Ottawa. Before-school and after-school programs will also be exempt from these new restrictions.

17 October 2020
Putin proposes one-year extension of New START treaty
He also lauded the New START treaty, for having successfully put a bridle on the arms race for about a decade. Foreign Minister Sergei Lavrov told Putin Friday that "intensive" consultations on the treaty are underway.

17 October 2020
China Is Making More Enemies Than Friends With Its War Waging Nature
These were the details of the news In the midst of the tension between America and China. for this day. This is widely seen as the country is preparing for war.

17 October 2020
SCOTUS allows Trump administration to end 2020 census count
In Arkansas, an operation to send people into hard-to-count neighborhoods was suspended two days before the count was ending. Montanans who have not yet done so should respond to the 2020 Census now at MY2020CENSUS.GOV or by calling 1-844-330-2020.

16 October 2020
COVID-19: Government will give 'detailed consideration' to recommended Level 5 restrictions
Ronan Glynn noted that they were seeing concerning reports of people going in to work despite experiencing symptoms of Covid-19. The recommendation comes less than two weeks after Nphet controversially recommended the level five restrictions.

16 October 2020
Twitter Alters Policy On Hacked Content After Blocked Biden Story
But it didn't alert its users as to why they couldn't share the link until hours later. The story has not been confirmed by other publications.